review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | J Mestecky | |
M W Russell | |||
M Kilian | |||
P2860 | cites work | Human protein HC and its IgA complex are inhibitors of neutrophil chemotaxis | Q24632349 |
The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains | Q28265873 | ||
Aggregation and Adherence of Streptococcus sanguis : Role of Human Salivary Immunoglobulin A | Q34101024 | ||
Immunoglobulin A: strategic defense initiative at the mucosal surface | Q34181777 | ||
The IgA1 proteases of pathogenic bacteria | Q34259591 | ||
Effects of local immunization with glucosyltransferase on colonization of hamsters by Streptococcus mutans | Q36331419 | ||
Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes | Q36346053 | ||
Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG | Q36349746 | ||
Subpopulations of human peripheral granulocyes and monocytes express receptors for IgA | Q36394850 | ||
Immunoglobulin A proteases in gram-negative bacteria isolated from human urinary tract infections | Q37079567 | ||
Immunoglobulin A-mediated hepatobiliary transport constitutes a natural pathway for disposing of bacterial antigens | Q37100648 | ||
Milk precipitins, circulating immune complexes, and IgA deficiency | Q37590844 | ||
IgA subclasses | Q39591155 | ||
Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. | Q39657235 | ||
Role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man. | Q39848757 | ||
Biologic function of the serum IgA system: modulation of complement-mediated effector mechanisms and conservation of antigenic mass | Q40152772 | ||
Retained antigen-binding activity of Fab alpha fragments of human monoclonal immunoglobulin A1 (IgA1) cleaved by IgA1 protease | Q40171584 | ||
Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae. | Q40176758 | ||
Immunobiology of dental caries: microbial aspects and local immunity | Q40317477 | ||
Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A. | Q40688162 | ||
Mucosal penetration of antigen in the presence or absence of serum-derived antibody | Q40838197 | ||
Suppression of human PMN bactericidal activity by human IgA paraproteins | Q40865948 | ||
Experimental studies on cholera immunization. II. Evidence for protective antitoxic immunity mediated by serum antibodies as well as local antibodies. | Q40913204 | ||
Suppression by IgA of IgG-mediated phagocytosis by human polymorphonuclear leucocytes | Q41004286 | ||
Reduction of phagocytosis, surface hydrophobicity and charge of Salmonella typhimurium 395 MR10 by reaction with secretory IgA (SIgA). | Q41034211 | ||
Elimination of intestinally absorbed antigen into the bile by IgA. | Q41592719 | ||
The effect of lysozyme on the complement-dependent bactericidal action of different antibody classes | Q44067879 | ||
Neutralizing secretory IgA and IgG do not inhibit attachment of transmissible gastroenteritis virus | Q45836917 | ||
Rat C3 conversion by rat anti-2,4,dinitrophenyl (DNP) hapten IgA immune precipitates | Q46535439 | ||
Lack of Opsonization Potential of 11S Human Secretory A | Q48017754 | ||
Natural anti-bacterial activity against Salmonella typhi by human T4+ lymphocytes armed with IgA antibodies | Q50204703 | ||
The effects of binding mouse IgA to dinitrophenylated Salmonella typhimurium on physicochemical properties and interaction with phagocytic cells. | Q50206847 | ||
IgA-dependent cell-mediated activity against enteropathogenic bacteria: distribution, specificity, and characterization of the effector cells | Q50207851 | ||
Mucosal barrier mechanisms. Interplay between secretory IgA (SIgA), IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes. | Q50214664 | ||
Receptor analogues and anti-pili antibodies as inhibitors of bacterial attachment in vivo and in vitro. | Q53922377 | ||
Effector mechanism of host resistance in murine giardiasis: specific IgG and IgA cell-mediated toxicity. | Q54453760 | ||
Activation of the alternative pathway of complement by human serum IgA. | Q54788488 | ||
Interference of IgA Protease with the Effect of Secretory IgA on Adherence of Oral Streptococci to Saliva-coated Hydroxyapatite | Q58234732 | ||
A hypothetical model for the development of invasive infection due to IgA1 protease-producing bacteria | Q58234738 | ||
Proportions and identity of IgA1-degrading bacteria in periodontal pockets from patients with juvenile and rapidly progressive periodontitis | Q58234743 | ||
[3] Immunoglobulin A (IgA) | Q58234753 | ||
Bacterium-induced cleavage of IgA in nasopharyngeal secretions from atopic children | Q58234770 | ||
Immune exclusion is a function of IgA | Q59060423 | ||
Antigenic specificity of antibodies in vaginal secretions during infection with Neisseria gonorrhoeae | Q64452261 | ||
Human immunoglobulin A: production of an Fc fragment by an enteric microbial proteolytic enzyme | Q67255224 | ||
Synergism between ecologic and immunologic control mechanisms of intestinal flora | Q67280402 | ||
Complement fixing abilities of IgA myeloma proteins and their fragments: the activation of complement through the classical pathway | Q67528803 | ||
Activation of the classical complement pathway by Fc fragment of human IgA | Q67550387 | ||
The effect of an IgA1 protease on immunoglobulins bound to the sperm surface and sperm cervical mucus penetrating ability | Q68161550 | ||
Interference of oral immunization with the intestinal absorption of heterologous albumin | Q68352449 | ||
IgA as a blocking factor in human malignant melanoma | Q68352700 | ||
Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues | Q68873188 | ||
IgA- and secretory IgA-opsonized S. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes | Q69135090 | ||
Studies on the opsonic activity of human secretory IgA using an in vitro phagocytosis system | Q69162499 | ||
Intestinal Uptake of Macromolecules: Effect of Oral Immunization | Q69375927 | ||
IgA-induced chemokinesis of human polymorphonuclear neutrophils: requirement of their Fc-alpha receptor | Q69406180 | ||
A novel IgA protease from Clostridium sp. capable of cleaving IgA1 and IgA2 A2m(1) but not IgA2 A2m(2) allotype paraproteins | Q69880576 | ||
Interaction of specific and innate factors of immunity: IgA enhances the antimicrobial effect of the lactoperoxidase system against Streptococcus mutans | Q70266443 | ||
The effect of antibody on the intestinal absorption of macromolecules and on intestinal permeability in adult mice | Q70338754 | ||
Inhibition of microbial IgA proteases by human secretory IgA and serum | Q70456486 | ||
Effect of locally induced intestinal anaphylaxis on the uptake of a bystander antigen | Q70688641 | ||
Cytofluorographic analysis of receptors for IgA on human polymorphonuclear cells and monocytes and the correlation of receptor expression with phagocytosis | Q71111427 | ||
The binding of human milk lactoferrin to immunoglobulin A | Q71353140 | ||
Suppression of leucocyte chemokinesis and chemotaxis by human IgA | Q71395061 | ||
The ability of IgA to inhibit the complement-mediated lysis of target red blood cells sensitized with IgG antibody | Q71409692 | ||
Ontogeny of the secretory immune system in man | Q71451618 | ||
The elimination of circulating complexes containing polymeric IgA by excretion in the bile | Q71477741 | ||
IgA paraprotein inhibition of human neutrophil chemotaxis. Reduced activity following treatment with IgA-specific protease from Neisseria gonorrhoeae | Q71508153 | ||
IgA antibody, antibody-dependent cellular cytotoxicity and prognosis in patients with nasopharyngeal carcinoma | Q72647229 | ||
Inhibition of Cutaneous Anaphylaxis and Arthus Reactions in the Mouse by Antigen-Specific IgA | Q72649761 | ||
Antimicrobial Effect of Human Serum IgA | Q72945464 | ||
IgA-mediated phagocytosis by mouse alveolar macrophages | Q93589430 | ||
Human secretory immunoglobulins. II. Salivary secretions from individuals with selectively excessive or defective synthesis of serum immunoglobulins | Q93695840 | ||
P433 | issue | 2 | |
P304 | page(s) | 296-303 | |
P577 | publication date | 1988-06-01 | |
P1433 | published in | Microbiological Reviews | Q26842868 |
P1476 | title | Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases | |
P478 | volume | 52 |
Q64082377 | : Invasion and Inflammation |
Q50020386 | A novel two-component system of Streptococcus sanguinis affecting functions associated with viability in saliva and biofilm formation |
Q34222728 | A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology. |
Q70230675 | Actions of three clostridial IgA proteases on distinct forms of immunoglobulin A molecules |
Q39822016 | Active release of bound antibody by Streptococcus mutans. |
Q68874217 | An enzyme-assessed microplate-assay for neutrophil adherence. I. IgA-induced adherence of human PMNs |
Q33870850 | Anti-caries DNA vaccine-induced secretory immunoglobulin A antibodies inhibit formation of Streptococcus mutans biofilms in vitro |
Q34532507 | Antigenic relationships among immunoglobulin A1 proteases from Haemophilus, Neisseria, and Streptococcus species. |
Q40269330 | Antigenic variation of immunoglobulin A1 proteases among sequential isolates of Haemophilus influenzae from healthy children and patients with chronic obstructive pulmonary disease |
Q72220412 | Assessing mucosal humoral immunity |
Q44302013 | Bacteroides-specific IgG and IgA subclass antibody-secreting cells isolated from chronically inflamed gingival tissues. |
Q36283935 | Breast Milk: A vital defense against infection |
Q35215948 | Candida albicans secreted aspartyl proteinases in virulence and pathogenesis |
Q33230043 | Characterization, distribution, and expression of novel genes among eight clinical isolates of Streptococcus pneumoniae |
Q36614194 | Chemoproteomic profiling of host and pathogen enzymes active in cholera |
Q34740040 | Chlamydial infection increases gonococcal colonization in a novel murine coinfection model. |
Q37055410 | Common themes in microbial pathogenicity |
Q35557559 | Comparative analysis of immunoglobulin A1 protease activity among bacteria representing different genera, species, and strains |
Q34988090 | Comparison of clinical and radiographic characteristics between nodular bronchiectatic form of nontuberculous mycobacterial lung disease and diffuse panbronchiolitis |
Q35545581 | Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women |
Q36642138 | Current status of meningococcal group B vaccine candidates: capsular or noncapsular? |
Q33886180 | Cysteine proteinases and the pathogenesis of amebiasis |
Q40149902 | Detection of immunoglobulin A1 protease-induced Fab alpha fragments on dental plaque bacteria |
Q33769074 | Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae |
Q40670059 | Evidence of bovine immunoglobulin G1 (IgG1) protease activity in partially purified culture supernate of Pasteurella haemolytica A1 |
Q39823340 | Evidence of recombination and an antigenically diverse immunoglobulin A1 protease among strains of Streptococcus pneumoniae |
Q34002354 | Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice |
Q36250210 | Expression of IgA Proteases by Haemophilus influenzae in the Respiratory Tract of Adults With Chronic Obstructive Pulmonary Disease |
Q37937205 | Gastrointestinal host defense and necrotizing enterocolitis |
Q57132989 | Glycan recognition at the saliva - Oral microbiome interface |
Q34531792 | Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity. |
Q37887598 | How pathogen-derived cysteine proteases modulate host immune responses |
Q33867635 | Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB |
Q37837985 | IgA modulates respiratory dysfunction as a sequela to pulmonary chlamydial infection as neonates |
Q69108603 | IgA subclasses of human colostral antibodies specific for microbial and food antigens |
Q74484228 | IgA1 protease production by bacteria colonizing the upper respiratory tract |
Q77586686 | Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice |
Q24548847 | Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice |
Q35774918 | Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. |
Q45733156 | Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus |
Q35230082 | Inhibition of Prevotella and Capnocytophaga immunoglobulin A1 proteases by human serum |
Q36972405 | Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-IgA) antibodies to cell surface protein antigen I/II: reversal by IgA1 protease cleavage |
Q40235118 | Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease |
Q40955839 | Interleukin-4 and interferon-gamma synergistically increase secretory component gene expression, but are additive in stimulating secretory immunoglobulin A release by Calu-3 airway epithelial cells |
Q74445998 | Intraspecies heterogeneity of immunoglobulin alpha-chain constant region genes in rhesus macaques |
Q33859127 | Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes |
Q40150932 | Lack of cleavage of immunoglobulin A (IgA) from rhesus monkeys by bacterial IgA1 proteases. |
Q52943284 | Levels of parotid and submandibular/sublingual salivary immunoglobulin A in response to experimental gingivitis in humans. |
Q24678296 | Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1 |
Q34386841 | Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae |
Q34207864 | Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura |
Q35753014 | Microorganisms and exacerbation of chronic obstructive pulmonary diseases: pathophysiological mechanisms |
Q36980617 | Molecular aspects of immunoglobulin A1 degradation by oral streptococci |
Q36750610 | Molecular heterogeneity of human IgA antibodies during an immune response. |
Q34431600 | Mucosal adjuvanticity of fibronectin-binding peptide (FBP) fused with Echinococcus multilocularis tetraspanin 3: systemic and local antibody responses |
Q34004276 | Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents |
Q35545804 | Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits. |
Q35588006 | Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria |
Q41880046 | Occurrence and evolution of the paralogous zinc metalloproteases IgA1 protease, ZmpB, ZmpC, and ZmpD in Streptococcus pneumoniae and related commensal species |
Q54951489 | Oral Bacterial and Fungal Microbiome Impacts Colorectal Carcinogenesis. |
Q34009973 | Oral microbial ecology and the role of salivary immunoglobulin A |
Q29615547 | Pathogenesis of group A streptococcal infections |
Q35781520 | Pioneer oral streptococci produce immunoglobulin A1 protease |
Q35684502 | Pneumococcal IgA1 protease subverts specific protection by human IgA1 |
Q64450753 | Porphyromonas gingivalis-specific serum IgG and IgA antibodies originate from immunoglobulin-secreting cells in inflamed gingiva |
Q36966799 | Proteolysis of bacterial membrane proteins by Neisseria gonorrhoeae type 2 immunoglobulin A1 protease |
Q33712649 | Quantitative analysis of age specific variation in the abundance of human female parotid salivary proteins |
Q40565010 | Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines |
Q35532963 | Recognition of immunoglobulin A1 by oral actinomyces and streptococcal lectins |
Q35698255 | Recombinant human IgA expressed in insect cells |
Q40476130 | Role of Serum Mycoplasma pneumoniae IgA, IgM, and IgG in the Diagnosis of Mycoplasma pneumoniae-Related Pneumonia in School-Age Children and Adolescents. |
Q33646143 | Salivary Immunoglobulin Gene Expression in Patients with Caries |
Q35104676 | Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin |
Q35431790 | Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease |
Q33609134 | Similar proportions of immunoglobulin A1 (IgA1) protease-producing streptococci in initial dental plaque of selectively IgA-deficient and normal individuals. |
Q36539205 | Specific IgA and metalloproteinase activity in bronchial secretions from stable chronic obstructive pulmonary disease patients colonized by Haemophilus influenzae |
Q33347255 | Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces |
Q30382858 | Streptococcal M protein: molecular design and biological behavior. |
Q93088973 | Streptococcus pneumoniae Evades Host Cell Phagocytosis and Limits Host Mortality Through Its Cell Wall Anchoring Protein PfbA |
Q38037527 | Structure and function of the Haemophilus influenzae autotransporters |
Q74255834 | Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines |
Q36988044 | Subclass distribution of salivary secretory immunoglobulin A antibodies to oral streptococci |
Q35778945 | Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin |
Q24634708 | The biology of Giardia spp |
Q68646299 | The specificity of the human neutrophil IgA receptor (Fc alpha R) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2 |
Q24307588 | The structure and function of human IgA |
Q33782648 | Transgenic mice secreting coronavirus neutralizing antibodies into the milk |
Q33559645 | Type V protein secretion pathway: the autotransporter story |
Q33606899 | Unexpectedly high levels of some presumably protective secretory immunoglobulin A antibodies to dental plaque bacteria in salivas of both caries-resistant and caries-susceptible subjects |
Q33997949 | Validation of a gastrointestinal explant system for measurement of mucosal antibody production. |
Q37360187 | Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells |
Search more.